|
RepliCel Life Sciences Inc. (RP) -
| Industry: | Biotechnology |
| RSP Eligible: | Yes |
| Market Maker: | No Market Maker |
 |
   
|
|||||||||||||||||||||||||||||||||||||||
 |
|||||
| Date/Time | Price | Change | Volume | Buyer | Seller |
| Jan 31, 11:45 | 0.410 | -0.340 | 5,000 | Mackie | Haywood |
| Dec 14, 11:23 | 0.750 | 0.000 | 25,000 | TD Securities | Mackie |
| Dec 14, 11:23 | 0.750 | 0.000 | 25,000 | TD Securities | Mackie |
| Nov 16, 12:48 | 0.750 | 0.000 | 27,000 | Mackie | Mackie |
 |
|
| Issued & Outstanding: | 45,025,054 |
| Reserved for Issuance: | 5,850,046 |
| Thin Float: | No |
|
||||||||||||||||||||
CNSX announced today a new strategic partnership with Innovate Calgary and Alberta Deal Generator (ADG). Innovate Calgary and CNSX have forged a partnership agreement to enhance and support the technology and startup sector in Canada.
>>>
>>>
CNSX Markets Inc. (“CNSX” or the “Exchange”) completed the second tranche of a financing, the first part of which was announced on December 17, 2012.
>>>
>>>
